Biofrontera (BFRI) Stock Statistics & Valuation Metrics

Biofrontera has a market cap or net worth of $13.19M. The enterprise value is $12.75M.

Biofrontera has 12,803,344 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biofrontera’s return on equity (ROE) is -1.01 and return on invested capital (ROIC) is -53.81%.

The current PE Ratio of Biofrontera is ―. Biofrontera’s PEG ratio is 0.00813.

In the last 12 months, Biofrontera had revenue of 41.70M and earned -10.54M in profits. Earnings per share was -1.04.

In the last 12 months, operating cash flow was -9.31M and capital expenditures -4.00K, giving a free cash flow of -9.32M billion.

Biofrontera pays an annual dividend of ―, resulting in a dividend yield of ―

Biofrontera upcoming earnings date is Aug 7, 2026, Before Open (Confirmed).

Biofrontera as a current ratio of 1.52, with Debt / Equity ratio of 127.25%

In the past 12 months, Biofrontera has paid 25.00K in taxes.

Biofrontera EV to EBITDA ratio is -0.67, with an EV/FCF ratio of -0.42.

Biofrontera has $6.32M in cash and marketable securities with $7.72M in debt, giving a net cash position of -$1.41M billion.

Gross margin is 82.79%, with operating margin of -21.94%, and net profit margin of -25.26%.

The average price target for Biofrontera is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy